July 6, 2020 / 11:48 PM / a month ago

BRIEF-Santen Pharmaceutical - Announces U.S. FDA Acceptance Of Premarket Approval (Pma) Application For De-128 (Microshunt) For Review

July 7 (Reuters) - Santen Pharmaceutical Co Ltd:

* SANTEN PHARMACEUTICAL CO LTD - ANNOUNCES U.S. FDA ACCEPTANCE OF PREMARKET APPROVAL (PMA) APPLICATION FOR DE-128 (MICROSHUNT) FOR REVIEW Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below